Supplementary Figure 1 from Erlotinib, Erlotinib–Sulindac Versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer
openalex（2023）
关键词
Clinical Practice Guidelines,Treatment Guidelines
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要